We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares

Delisted

GMDA was delisted on the 5th of April, 2024.

55 hedge funds and large institutions have $29.1M invested in Gamida Cell Ltd. Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more call options, than puts

Call options by funds: $137K | Put options by funds: $50K

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

11% less funds holding

Funds holding: 6255 (-7)

24% less capital invested

Capital invested by funds: $38.3M → $29.1M (-$9.2M)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

Holders
55
Holders Change
-7
Holders Change %
-11.29%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
11
Reduced
12
Closed
21
Calls
$137K
Puts
$50K
Net Calls
+$87K
Net Calls Change
-$214K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$8.93M -$575K -363,542 -5%
RSCM
2
Rock Springs Capital Management
Maryland
$5.31M
MIH
3
Meitav Investment House
Israel
$4.63M
KHLMVGHM
4
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Israel
$2.8M
Federated Hermes
5
Federated Hermes
Pennsylvania
$2M +$14.6K +9,252 +0.6%
KHLMTHM
6
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet
Israel
$1.01M
Mariner
7
Mariner
Kansas
$930K +$8.09K +5,118 +0.7%
LCS
8
Levin Capital Strategies
New York
$608K +$706K +446,556 +1,786%
JP Morgan Chase
9
JP Morgan Chase
New York
$544K -$3.75K -2,370 -0.6%
Marshall Wace
10
Marshall Wace
United Kingdom
$404K -$88K -55,692 -15%
YAVAPFMC
11
Yahav Achim Ve Achayot - Provident Funds Management Company
Israel
$221K
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$201K +$11.9K +7,534 +5%
FIA
13
FNY Investment Advisers
New York
$197K +$242K +153,000 New
BlackRock
14
BlackRock
New York
$165K -$525K -331,817 -72%
Morgan Stanley
15
Morgan Stanley
New York
$163K -$24.4K -15,403 -11%
Victory Capital Management
16
Victory Capital Management
Texas
$136K -$14.5K -9,195 -8%
E
17
Ergoteles
New York
$95.5K +$117K +74,032 New
PTP
18
Platform Technology Partners
New York
$86.5K +$10.3K +6,500 +11%
SYBT
19
Stock Yards Bank & Trust
Kentucky
$65K -$31.6K -20,000 -29%
ML
20
McAdam LLC
Pennsylvania
$65K
CS
21
Credit Suisse
Switzerland
$61.3K +$75.1K +47,500 New
KI
22
Kapitalo Investimentos
Brazil
$56.6K +$69.4K +43,900 New
Goldman Sachs
23
Goldman Sachs
New York
$47.6K -$69.9K -44,223 -55%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$46K
Citadel Advisors
25
Citadel Advisors
Florida
$38.9K +$7.61K +4,813 +19%

GMDA Hedge Fund Activity: Q4 2022 in Review

55 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q4 2022, worth a combined $29.1M — down 24% from $38.3M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of GMDA and 14 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was Levin Capital Strategies, adding an estimated $706K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $978K sold.

  • 55 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q4 2022, down from 62 in Q3 2022.
  • Funds reported $29.1M of Gamida Cell Ltd. Ordinary Shares stock for Q4 2022, down 24% quarter-over-quarter.
  • 14 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q4 2022 and 21 closed out, a net change of -7 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q4 2022 was Levin Capital Strategies, an estimated $706K added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q4 2022 was DAFNA Capital Management, an estimated $978K sold.

Based on aggregated 13F filings for Q4 2022.